The difference between pantoprazole sodium enteric-coated tablets and rabeprazole is reflected in the drug composition. Pantoprazole sodium enteric-coated tablets, whose main ingredient is pantoprazole sodium, belongs to the proton pump inhibitor, can effectively inhibit the secretion of gastric acid, applicable to peptic ulcer, reflux esophagitis, Droege’s syndrome and so on. The main ingredient of rabeprazole is rabeprazole sodium, while rabeprazole is a benzimidazole compound, which belongs to proton pump inhibitor. It is suitable for acid-related diseases such as gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux esophagitis, and Dreh-El syndrome. In addition, the medication should be used under the guidance of a professional doctor.